Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/21/2010WO2010119881A1 Indoline compound
10/21/2010WO2010119875A1 Fused pyrrolopyridine derivative
10/21/2010WO2010119741A1 Preparation for external use
10/21/2010WO2010119700A1 Novel compound having 3-heteroarylpyrimidin-4-(3h)-one structure and pharmaceutical preparation containing same
10/21/2010WO2010119698A1 Head-and-neck tumor proliferation inhibitor
10/21/2010WO2010119674A1 Pharmaceutical composition for ameliorating and/or preventing leptin resistance, and use thereof
10/21/2010WO2010119638A1 Biofilm formation inhibitor
10/21/2010WO2010119385A1 A medicinal fusidic acid cream made using sodium fusidate and incorporating a biopolymer and a process to make it
10/21/2010WO2010119383A1 A medicinal cream made using framycetin sulphate cream and chitosan, and a process to make it
10/21/2010WO2010119368A2 A medicinal cream made using miconazole nitrate and chitosan, and a process to make the same
10/21/2010WO2010119366A2 A medicinal cream made using fluticasone propionate, and chitosan, and a process to make the same
10/21/2010WO2010119347A1 Netupitant for use in treating bladder dysfunction
10/21/2010WO2010119344A1 Compounds for the treatment of mitochondrial diseases
10/21/2010WO2010119319A1 Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
10/21/2010WO2010119306A1 Use of multi-kinase inhibitors in the treatment of vascular hyperpermeability
10/21/2010WO2010119285A1 Imidazo [1,2-a]pyridine derivatives as fgfr kinase inhibitors for use in therapy
10/21/2010WO2010119284A1 Bicyclic heterocyclyl derivatives as fgfr kinase inhibitors for therapeutic use
10/21/2010WO2010119264A1 Imidazopyrazines for use as kinase inhibitors
10/21/2010WO2010119222A1 Derivatives of n-[(7-aza-bicyclo[2.2.1]hept-1-yl)-aryl-methyl]-benzamide, preparation thereof, and therapeutic use thereof
10/21/2010WO2010119194A1 Imidazolidine-2,4-dione derivatives and use thereof as a medicament
10/21/2010WO2010119193A1 Imidazolidine-2,4-dione derivatives, and use thereof as a cancer drug
10/21/2010WO2010119161A2 Antiepileptic, hypocholesterolemic and neuroprotective compound
10/21/2010WO2010119158A1 Polycationic amphiphilic cyclooligosaccharides and the use thereof as molecular transporters
10/21/2010WO2010119132A1 Pharmaceutical composition comprising glycerol, white soft paraffin and liquid paraffin for the treatment of uremic xerosis and/or pruritus
10/21/2010WO2010119114A1 Bacterial strains having an outstanding ability to produce menaquinone
10/21/2010WO2010119102A2 Pharmaceutical composition for treating dermatological autoimmune diseases
10/21/2010WO2010119078A1 Indole derivative modulators of the alpha 7 nachr
10/21/2010WO2010119050A1 New rac1 inhibitors as potential pharmacological agents for heart failure treatment
10/21/2010WO2010119036A1 Novel post-translational fibrinogen variants
10/21/2010WO2010119030A1 Method for on-demand contraception using levonorgestrel or norgestrel
10/21/2010WO2010119029A1 Method for on-demand contraception
10/21/2010WO2010118992A1 Process for preparation of endothelial receptor antagonist (bosentan)
10/21/2010WO2010118986A1 Fluoro substituted pyrimidine compounds as jak3 inhibitors
10/21/2010WO2010118968A1 No-donor aspirin derivatives
10/21/2010WO2010118921A1 Novel p2x7r antagonists and their use
10/21/2010WO2010118889A1 Synthesis of 1-amino-1,3,3,5,5-pentamethylcyclohexane mesylate
10/21/2010WO2010118866A1 Trehalulose-containing composition, its preparation and use
10/21/2010WO2010118856A1 Use of conjugated linoleic acid
10/21/2010WO2010118852A1 ( pyrazol-3-yl) -1, 3, 4-thiadiazol-2-amine and ( pyrazol-3-yl) -1, 3, 4-thiazol-2-amine compounds
10/21/2010WO2010118789A1 Hydroxytyrosol combinations for enhancing mitochondrial function and energy production
10/21/2010WO2010118761A1 Compositions rich in omega-3 fatty acids with a low content in phytanic acid
10/21/2010WO2010118683A1 Targeted sustained-release microsphere of vascular occlusive agent containing sodium alginate and sorafenib, production method and use thereof
10/21/2010WO2010118675A1 New use of neferine
10/21/2010WO2010118639A1 Amlodipine microsphere agent, production method and use thereof
10/21/2010WO2010118598A1 Crystal form a of furanodiene, the preparation method and the useful for preparing the antitumor drug thereof
10/21/2010WO2010118555A1 Use of acrylate resin and grafted polymer thereof in preparation of hemostatic dressing and preparation method thereof
10/21/2010WO2010118524A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof
10/21/2010WO2010118516A1 Compositions for sublingual drug delivery and methods of use thereof
10/21/2010WO2010118474A1 Compounds affecting glycemic index
10/21/2010WO2010118461A1 Gel compositions for administration of pharmaceutically active compounds
10/21/2010WO2010118458A1 A multidose package, course and method of treatment for delivering predetermined multiple doses of a pharmaceutical
10/21/2010WO2010099139A3 Combination of an either an anti-igf-ir- antibody or an igf binding protein and a small molecule igf-ir kinease inhibitor
10/21/2010WO2010099054A3 Soluble guanylate cyclase activators
10/21/2010WO2010097576A9 1, 4-disubstituted piperidines as vasopressin receptor via antagonists
10/21/2010WO2010097255A3 Beverage containing tea solids, a polymeric polyphenol, added protein and added anionic polysaccharide
10/21/2010WO2010095964A4 A method for amphiphilic drug loading in liposomes by ion gradient
10/21/2010WO2010094761A3 Oregano extract for alertness
10/21/2010WO2010094734A3 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation
10/21/2010WO2010092163A3 Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics
10/21/2010WO2010091892A3 Alkylamido compounds and uses thereof
10/21/2010WO2010091683A3 Device and method for producing pharmaceutically highly refined particles and for coating said particles in microreactors
10/21/2010WO2010091299A3 Combination of a 17 alpha-hydr0xylase/c17, 20-lyase inhibitor with an additional therapeutic agent
10/21/2010WO2010089327A3 Indole derivatives as anticancer agents
10/21/2010WO2010087594A3 Cd93 or use of soluble fragment thereof
10/21/2010WO2010087577A3 Use of thymus capitatus extract, satureja hortensis extract, or carvacrol for treating metabolic diseases
10/21/2010WO2010086878A3 Thyroid receptor modulators
10/21/2010WO2010084499A3 Bicyclic heterocyclic spiro compounds
10/21/2010WO2010081647A3 Sgc stimulators of sgc activators in combination with pde5 inhbitors for the treatment of erectile dysfunction
10/21/2010WO2010077928A3 Flavononol renin inhibitor compounds and methods of use thereof
10/21/2010WO2010077589A3 Stat3 inhibitors and therapeutic methods using the same
10/21/2010WO2010077101A3 Novel thiazolidinedione derivative and use thereof
10/21/2010WO2010076813A4 Thienopyridines as pharmacologically active agents
10/21/2010WO2010068947A3 Nuclear export inhibitors of topoisomerase ii alpha
10/21/2010WO2010068877A3 Compounds that bind oxysterol binding proteins, and methods of use thereof
10/21/2010WO2010068866A3 Therapeutic particles suitable for parenteral administration and methods of making and using same
10/21/2010WO2010068056A3 Composition containing glucosamine or glucosamine derivative for preventing or treating hemadostenosis and restenosis
10/21/2010WO2010066810A8 Transdermal pharmaceutical compositions comprising a serm
10/21/2010WO2010062742A3 Methods for freparation and use of marrow infiltrating lymphocytes (mils)
10/21/2010WO2010062122A3 Composition for preventing or treating artherosclerosis
10/21/2010WO2010059967A3 Amide inhibitors of renin
10/21/2010WO2010056985A3 Treatment of proteinopathies using a farnesyl transferase inhibitor
10/21/2010WO2010056044A3 Novel compound acting as a vanilloid receptor antagonist, isomer or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same
10/21/2010WO2010048358A3 Ethoxyphenylmethyl inhibitors of sglt2
10/21/2010WO2010026602A3 Pharmaceutical compositions containing calcium channel blockers for treatment of tuberculosis
10/21/2010WO2010022177A3 Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use
10/21/2010WO2010008847A3 Pi3k/m tor inhibitors
10/21/2010WO2009155095A3 Methods to control qoi-resistant fungal pathogens
10/21/2010WO2009152917A4 Stabilization of the composition of a mixture
10/21/2010WO2009140749A3 Extract of hancornia speciosa and pharmaceutical composition thereof
10/21/2010WO2009126515A8 Compounds and compositions as protein kinase inhibitors
10/21/2010WO2009126514A8 Compounds and compositions as kinase inhibitors
10/21/2010WO2009118516A8 Process for the preparation of donepezil hydrochloride
10/21/2010WO2009112231A3 Drospirenone/ 17beta-estradiol regimen, pharmaceutical combination product and kit for performing this regimen
10/21/2010WO2009110007A8 Spiro derivatives of parthenin as novel anticancer agents
10/21/2010WO2009100656A8 2-methylene-5-substituted methylene cyclopentanone derivatives and use thereof
10/21/2010WO2009096245A9 Pharmaceutical composition and combined agent
10/21/2010WO2009089024A8 Neuroactive steroid compositions and methods of use therefor
10/21/2010WO2009020470A3 Cgrp receptor antagonists
10/21/2010WO2007094548A3 Berberrubine derivatives having antifungal activities
10/21/2010US20100269183 Micro-rnas that control myosin expression and myofiber identity
1 ... 2037 2038 2039 2040 2041 2042 2043 2044 2045 2046 2047 2048 2049 2050 2051 2052 2053 2054 2055 2056 2057 ... 7860